INNPF · Insider Trading
INNOCAN PHARMA CORP
Every open-market purchase and sale reported by INNPF officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
No SEC Form 4 insider filings are on file for INNPF.
See the INNPF full quote page for its other filings.
More on INNPF
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.